| Name | Market | Market CAP | Share price | Daily share movement |
|---|---|---|---|---|
| 600 Group | AIM | £10.34 m | 8.80 GBX | -6.13% |
| 712 North | Unlisted | 0.00 | 0.00% | |
| 7D Surgical | Unlisted | 0.00 | 0.00% | |
| 7Digital Group PLC | AIM | £34.03 m | 1.25 GBX | -5.66% |
| 808 Renewable Energy Corp. | PINK | $23.5 m | 0.34 USD | 0.00% |
| 88 Energy Ltd | AIM | £66.52 m | 0.55 GBX | -2.32% |
| 888 Holdings | LSE | £1.16 billion | 313.50 GBX | 0.48% |
| 8common | ASX | $33.07 m | 0.17 AUD | -2.94% |
| 8I Holdings Limited | ASX | $65.12 m | 0.18 AUD | 0.00% |
| 8x8 Inc | NYSE | $3.54 billion | 32.91 USD | -0.03% |
| 9 Spokes International Ltd | ASX | $31.36 m | 0.02 AUD | 0.00% |
| 99 Bitcoins | Unlisted (US) | 0.00 | 0.00% | |
| 99 Wuxian Ltd | ASX | 0.00 | 0.00% | |
| A&J Mucklow Group PLC | LSE | 0.00 | 0.00% | |
| A-Cap Resources Ltd | ASX | $38.36 m | 0.04 AUD | 7.32% |
| A-Mark Precious Metals Inc | NASDAQ | $203.91 m | 28.31 USD | -0.14% |
| A.I.S. Resources Limited | TSX-V | 0.00 | 0.00% | |
| A.O. Smith | NYSE | $11.91 billion | 62.48 USD | 2.36% |
| A.T. Cross | NASDAQ | 0.00 | 0.00% | |
| A1 Consolidated Gold | ASX | 0.00 | 0.00% | |
| A1 Investments & Resources | ASX | $16.42 m | 0.00 AUD | 0.00% |
| A10 Networks Inc | NYSE | $700.86 m | 9.18 USD | 0.99% |
| A123 Systems | NASDAQ | $290.79 m | 11.50 USD | 5.41% |
| A2 Milk Co Ltd. | PINK | $5.36 billion | 7.21 USD | 0.23% |
| AA PLC | LSE | £218.24 m | 34.95 GBX | 0.00% |
| AAC Clyde Space AB | OTCQX | $49.61 m | 0.34 USD | -6.60% |
| AAC Holdings Inc. | PINK | $0.00 | 0.00 USD | 0.00% |
| AAR | NYSE | $1.47 billion | 41.77 USD | 2.45% |
| AB Dynamics PLC | AIM | £456.22 m | 2,020.00 GBX | -1.94% |
| AB Science, Paris | PINK | $840.72 m | 18.96 USD | -0.16% |
| AB&T Financial Corp. (NC) | PINK | $960.55 k | 0.36 USD | -20.00% |
| Abacus Health Products, Inc. | CSE | 0.00 | 0.00% | |
| Abacus Mining & Exploration Corp. | TSX-V | $11.1 m | 0.15 CAD | 3.45% |
| Abacus Property Group | ASX | $2.19 billion | 2.67 AUD | 0.00% |
| Abal Group PLC | Unlisted | 0.00 | 0.00% | |
| Abattis Bioceuticals | CSE | 0.00 | 0.00% | |
| Abbey plc | AIM | £334.03 m | 1,600.00 GBX | 0.00% |
| Abbey Protection | Unlisted (UK) | 0.00 | 0.00% | |
| Abbeycrest | LSE | 0.00 | 0.00% | |
| Abbott Laboratories | NYSE | $207.71 billion | 117.25 USD | 1.07% |